List of Tables
Table 1. Global Bioequivalent Peptide Drugs Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Bioequivalent Peptide Drugs Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Bioequivalent Peptide Drugs Market Competitive Situation by Manufacturers in 2024
Table 4. Global Bioequivalent Peptide Drugs Sales (Units) of Key Manufacturers (2020-2025)
Table 5. Global Bioequivalent Peptide Drugs Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Bioequivalent Peptide Drugs Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Bioequivalent Peptide Drugs Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Bioequivalent Peptide Drugs Average Price (US$/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Bioequivalent Peptide Drugs, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Bioequivalent Peptide Drugs, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Bioequivalent Peptide Drugs, Product Type & Application
Table 12. Global Key Manufacturers of Bioequivalent Peptide Drugs, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Bioequivalent Peptide Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Bioequivalent Peptide Drugs as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Bioequivalent Peptide Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Bioequivalent Peptide Drugs Sales by Region (2020-2025) & (Units)
Table 18. Global Bioequivalent Peptide Drugs Sales Market Share by Region (2020-2025)
Table 19. Global Bioequivalent Peptide Drugs Sales by Region (2026-2031) & (Units)
Table 20. Global Bioequivalent Peptide Drugs Sales Market Share by Region (2026-2031)
Table 21. Global Bioequivalent Peptide Drugs Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Bioequivalent Peptide Drugs Revenue Market Share by Region (2020-2025)
Table 23. Global Bioequivalent Peptide Drugs Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Bioequivalent Peptide Drugs Revenue Market Share by Region (2026-2031)
Table 25. North America Bioequivalent Peptide Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Bioequivalent Peptide Drugs Sales by Country (2020-2025) & (Units)
Table 27. North America Bioequivalent Peptide Drugs Sales by Country (2026-2031) & (Units)
Table 28. North America Bioequivalent Peptide Drugs Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Bioequivalent Peptide Drugs Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Bioequivalent Peptide Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Bioequivalent Peptide Drugs Sales by Country (2020-2025) & (Units)
Table 32. Europe Bioequivalent Peptide Drugs Sales by Country (2026-2031) & (Units)
Table 33. Europe Bioequivalent Peptide Drugs Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Bioequivalent Peptide Drugs Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Bioequivalent Peptide Drugs Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Bioequivalent Peptide Drugs Sales by Region (2020-2025) & (Units)
Table 37. Asia Pacific Bioequivalent Peptide Drugs Sales by Region (2026-2031) & (Units)
Table 38. Asia Pacific Bioequivalent Peptide Drugs Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Bioequivalent Peptide Drugs Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Bioequivalent Peptide Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Bioequivalent Peptide Drugs Sales by Country (2020-2025) & (Units)
Table 42. Latin America Bioequivalent Peptide Drugs Sales by Country (2026-2031) & (Units)
Table 43. Latin America Bioequivalent Peptide Drugs Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Bioequivalent Peptide Drugs Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Bioequivalent Peptide Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Bioequivalent Peptide Drugs Sales by Country (2020-2025) & (Units)
Table 47. Middle East and Africa Bioequivalent Peptide Drugs Sales by Country (2026-2031) & (Units)
Table 48. Middle East and Africa Bioequivalent Peptide Drugs Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Bioequivalent Peptide Drugs Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Bioequivalent Peptide Drugs Sales (Units) by Type (2020-2025)
Table 51. Global Bioequivalent Peptide Drugs Sales (Units) by Type (2026-2031)
Table 52. Global Bioequivalent Peptide Drugs Sales Market Share by Type (2020-2025)
Table 53. Global Bioequivalent Peptide Drugs Sales Market Share by Type (2026-2031)
Table 54. Global Bioequivalent Peptide Drugs Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Bioequivalent Peptide Drugs Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Bioequivalent Peptide Drugs Revenue Market Share by Type (2020-2025)
Table 57. Global Bioequivalent Peptide Drugs Revenue Market Share by Type (2026-2031)
Table 58. Global Bioequivalent Peptide Drugs Price (US$/Unit) by Type (2020-2025)
Table 59. Global Bioequivalent Peptide Drugs Price (US$/Unit) by Type (2026-2031)
Table 60. Global Bioequivalent Peptide Drugs Sales (Units) by Application (2020-2025)
Table 61. Global Bioequivalent Peptide Drugs Sales (Units) by Application (2026-2031)
Table 62. Global Bioequivalent Peptide Drugs Sales Market Share by Application (2020-2025)
Table 63. Global Bioequivalent Peptide Drugs Sales Market Share by Application (2026-2031)
Table 64. Global Bioequivalent Peptide Drugs Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Bioequivalent Peptide Drugs Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Bioequivalent Peptide Drugs Revenue Market Share by Application (2020-2025)
Table 67. Global Bioequivalent Peptide Drugs Revenue Market Share by Application (2026-2031)
Table 68. Global Bioequivalent Peptide Drugs Price (US$/Unit) by Application (2020-2025)
Table 69. Global Bioequivalent Peptide Drugs Price (US$/Unit) by Application (2026-2031)
Table 70. Eli Lilly and Company Company Information
Table 71. Eli Lilly and Company Description and Business Overview
Table 72. Eli Lilly and Company Bioequivalent Peptide Drugs Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 73. Eli Lilly and Company Bioequivalent Peptide Drugs Product
Table 74. Eli Lilly and Company Recent Developments/Updates
Table 75. Alvogen Company Information
Table 76. Alvogen Description and Business Overview
Table 77. Alvogen Bioequivalent Peptide Drugs Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 78. Alvogen Bioequivalent Peptide Drugs Product
Table 79. Alvogen Recent Developments/Updates
Table 80. Pfenex Company Information
Table 81. Pfenex Description and Business Overview
Table 82. Pfenex Bioequivalent Peptide Drugs Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 83. Pfenex Bioequivalent Peptide Drugs Product
Table 84. Pfenex Recent Developments/Updates
Table 85. HEC Pharm Company Information
Table 86. HEC Pharm Description and Business Overview
Table 87. HEC Pharm Bioequivalent Peptide Drugs Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 88. HEC Pharm Bioequivalent Peptide Drugs Product
Table 89. HEC Pharm Recent Developments/Updates
Table 90. Bachem Company Information
Table 91. Bachem Description and Business Overview
Table 92. Bachem Bioequivalent Peptide Drugs Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 93. Bachem Bioequivalent Peptide Drugs Product
Table 94. Bachem Recent Developments/Updates
Table 95. Bharat Pharmaceuticals Company Information
Table 96. Bharat Pharmaceuticals Description and Business Overview
Table 97. Bharat Pharmaceuticals Bioequivalent Peptide Drugs Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 98. Bharat Pharmaceuticals Bioequivalent Peptide Drugs Product
Table 99. Bharat Pharmaceuticals Recent Developments/Updates
Table 100. Kingpep Biotechnology Company Information
Table 101. Kingpep Biotechnology Description and Business Overview
Table 102. Kingpep Biotechnology Bioequivalent Peptide Drugs Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 103. Kingpep Biotechnology Bioequivalent Peptide Drugs Product
Table 104. Kingpep Biotechnology Recent Developments/Updates
Table 105. Ambio Pharmaceuticals Company Information
Table 106. Ambio Pharmaceuticals Description and Business Overview
Table 107. Ambio Pharmaceuticals Bioequivalent Peptide Drugs Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 108. Ambio Pharmaceuticals Bioequivalent Peptide Drugs Product
Table 109. Ambio Pharmaceuticals Recent Developments/Updates
Table 110. Jiangsu Sinopep Allsino Biopharmaceutical Company Information
Table 111. Jiangsu Sinopep Allsino Biopharmaceutical Description and Business Overview
Table 112. Jiangsu Sinopep Allsino Biopharmaceutical Bioequivalent Peptide Drugs Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 113. Jiangsu Sinopep Allsino Biopharmaceutical Bioequivalent Peptide Drugs Product
Table 114. Jiangsu Sinopep Allsino Biopharmaceutical Recent Developments/Updates
Table 115. Shanghai Shyndec Pharmaceutical Company Information
Table 116. Shanghai Shyndec Pharmaceutical Description and Business Overview
Table 117. Shanghai Shyndec Pharmaceutical Bioequivalent Peptide Drugs Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 118. Shanghai Shyndec Pharmaceutical Bioequivalent Peptide Drugs Product
Table 119. Shanghai Shyndec Pharmaceutical Recent Developments/Updates
Table 120. Shenzhen Salubris Pharmaceuticals Company Information
Table 121. Shenzhen Salubris Pharmaceuticals Description and Business Overview
Table 122. Shenzhen Salubris Pharmaceuticals Bioequivalent Peptide Drugs Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 123. Shenzhen Salubris Pharmaceuticals Bioequivalent Peptide Drugs Product
Table 124. Shenzhen Salubris Pharmaceuticals Recent Developments/Updates
Table 125. Shanghai United Cell Biotechnology Company Information
Table 126. Shanghai United Cell Biotechnology Description and Business Overview
Table 127. Shanghai United Cell Biotechnology Bioequivalent Peptide Drugs Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 128. Shanghai United Cell Biotechnology Bioequivalent Peptide Drugs Product
Table 129. Shanghai United Cell Biotechnology Recent Developments/Updates
Table 130. Shenzhen JYMed Technology Company Information
Table 131. Shenzhen JYMed Technology Description and Business Overview
Table 132. Shenzhen JYMed Technology Bioequivalent Peptide Drugs Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 133. Shenzhen JYMed Technology Bioequivalent Peptide Drugs Product
Table 134. Shenzhen JYMed Technology Recent Developments/Updates
Table 135. Wuxi Asiapeptide Biotechnology Company Information
Table 136. Wuxi Asiapeptide Biotechnology Description and Business Overview
Table 137. Wuxi Asiapeptide Biotechnology Bioequivalent Peptide Drugs Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 138. Wuxi Asiapeptide Biotechnology Bioequivalent Peptide Drugs Product
Table 139. Wuxi Asiapeptide Biotechnology Recent Developments/Updates
Table 140. Key Raw Materials Lists
Table 141. Raw Materials Key Suppliers Lists
Table 142. Bioequivalent Peptide Drugs Distributors List
Table 143. Bioequivalent Peptide Drugs Customers List
Table 144. Bioequivalent Peptide Drugs Market Trends
Table 145. Bioequivalent Peptide Drugs Market Drivers
Table 146. Bioequivalent Peptide Drugs Market Challenges
Table 147. Bioequivalent Peptide Drugs Market Restraints
Table 148. Research Programs/Design for This Report
Table 149. Key Data Information from Secondary Sources
Table 150. Key Data Information from Primary Sources
Table 151. Authors List of This Report
List of Figures
Figure 1. Product Picture of Bioequivalent Peptide Drugs
Figure 2. Global Bioequivalent Peptide Drugs Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Bioequivalent Peptide Drugs Market Share by Type: 2024 & 2031
Figure 4. Teriparatide(Forteo) Product Picture
Figure 5. Teduglutide(Gattex) Product Picture
Figure 6. Liraglutide(Victoza) Product Picture
Figure 7. Global Bioequivalent Peptide Drugs Market Value by Application (2020-2031) & (US$ Million)
Figure 8. Global Bioequivalent Peptide Drugs Market Share by Application: 2024 & 2031
Figure 9. Short Bowel Syndrome
Figure 10. Osteoporosis
Figure 11. Type 2 Diabetes
Figure 12. Others
Figure 13. Global Bioequivalent Peptide Drugs Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Bioequivalent Peptide Drugs Market Size (2020-2031) & (US$ Million)
Figure 15. Global Bioequivalent Peptide Drugs Sales (2020-2031) & (Units)
Figure 16. Global Bioequivalent Peptide Drugs Average Price (US$/Unit) & (2020-2031)
Figure 17. Bioequivalent Peptide Drugs Report Years Considered
Figure 18. Bioequivalent Peptide Drugs Sales Share by Manufacturers in 2024
Figure 19. Global Bioequivalent Peptide Drugs Revenue Share by Manufacturers in 2024
Figure 20. Global 5 and 10 Largest Bioequivalent Peptide Drugs Players: Market Share by Revenue in Bioequivalent Peptide Drugs in 2024
Figure 21. Bioequivalent Peptide Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 22. Global Bioequivalent Peptide Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 23. North America Bioequivalent Peptide Drugs Sales Market Share by Country (2020-2031)
Figure 24. North America Bioequivalent Peptide Drugs Revenue Market Share by Country (2020-2031)
Figure 25. United States Bioequivalent Peptide Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 26. Canada Bioequivalent Peptide Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 27. Europe Bioequivalent Peptide Drugs Sales Market Share by Country (2020-2031)
Figure 28. Europe Bioequivalent Peptide Drugs Revenue Market Share by Country (2020-2031)
Figure 29. Germany Bioequivalent Peptide Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. France Bioequivalent Peptide Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. U.K. Bioequivalent Peptide Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Italy Bioequivalent Peptide Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. Russia Bioequivalent Peptide Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 34. Asia Pacific Bioequivalent Peptide Drugs Sales Market Share by Region (2020-2031)
Figure 35. Asia Pacific Bioequivalent Peptide Drugs Revenue Market Share by Region (2020-2031)
Figure 36. China Bioequivalent Peptide Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. Japan Bioequivalent Peptide Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. South Korea Bioequivalent Peptide Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. India Bioequivalent Peptide Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Australia Bioequivalent Peptide Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. China Taiwan Bioequivalent Peptide Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Southeast Asia Bioequivalent Peptide Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Latin America Bioequivalent Peptide Drugs Sales Market Share by Country (2020-2031)
Figure 44. Latin America Bioequivalent Peptide Drugs Revenue Market Share by Country (2020-2031)
Figure 45. Mexico Bioequivalent Peptide Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Brazil Bioequivalent Peptide Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Argentina Bioequivalent Peptide Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Middle East and Africa Bioequivalent Peptide Drugs Sales Market Share by Country (2020-2031)
Figure 49. Middle East and Africa Bioequivalent Peptide Drugs Revenue Market Share by Country (2020-2031)
Figure 50. Turkey Bioequivalent Peptide Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. Saudi Arabia Bioequivalent Peptide Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. UAE Bioequivalent Peptide Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. Global Sales Market Share of Bioequivalent Peptide Drugs by Type (2020-2031)
Figure 54. Global Revenue Market Share of Bioequivalent Peptide Drugs by Type (2020-2031)
Figure 55. Global Bioequivalent Peptide Drugs Price (US$/Unit) by Type (2020-2031)
Figure 56. Global Sales Market Share of Bioequivalent Peptide Drugs by Application (2020-2031)
Figure 57. Global Revenue Market Share of Bioequivalent Peptide Drugs by Application (2020-2031)
Figure 58. Global Bioequivalent Peptide Drugs Price (US$/Unit) by Application (2020-2031)
Figure 59. Bioequivalent Peptide Drugs Value Chain
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
